Global Reduction in Unvaccinated Children, But Impact of Funding Shortage Is Yet to Hit 15/07/2026 Disha Shetty Nearly 90% of infants globally received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine in 2025, while around one-third of girls globally received at least one dose of Human Papillomavirus (HPV) vaccine, which protects against cervical cancer. This is according to the annual World Health Organization (WHO)-UNICEF Estimates of National Immunization […] Continue reading -> A Regional Approach to HPV Vaccine Design Can Advance Equity and Cervical Cancer Elimination 13/07/2026 Marco Cavaleri HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa. The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading -> Despite Frictions, Global Fund Asserts Confidentiality Rules and Schedule 08/07/2026 Felix Sassmannshausen The election of the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria will move forward on schedule, according to a statement released by the organisation on Tuesday, 7 July. This announcement follows rumours that the nomination process might be restarted after the names of several US candidates who were reportedly […] Continue reading -> Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Five Years after Landmark Diabetes Initiative: Cause to Celebrate but Even More to Accomplish 08/06/2026 Sophia Samantaroy The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading -> Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
A Regional Approach to HPV Vaccine Design Can Advance Equity and Cervical Cancer Elimination 13/07/2026 Marco Cavaleri HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa. The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading -> Despite Frictions, Global Fund Asserts Confidentiality Rules and Schedule 08/07/2026 Felix Sassmannshausen The election of the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria will move forward on schedule, according to a statement released by the organisation on Tuesday, 7 July. This announcement follows rumours that the nomination process might be restarted after the names of several US candidates who were reportedly […] Continue reading -> Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Five Years after Landmark Diabetes Initiative: Cause to Celebrate but Even More to Accomplish 08/06/2026 Sophia Samantaroy The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading -> Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
Despite Frictions, Global Fund Asserts Confidentiality Rules and Schedule 08/07/2026 Felix Sassmannshausen The election of the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria will move forward on schedule, according to a statement released by the organisation on Tuesday, 7 July. This announcement follows rumours that the nomination process might be restarted after the names of several US candidates who were reportedly […] Continue reading -> Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Five Years after Landmark Diabetes Initiative: Cause to Celebrate but Even More to Accomplish 08/06/2026 Sophia Samantaroy The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading -> Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Five Years after Landmark Diabetes Initiative: Cause to Celebrate but Even More to Accomplish 08/06/2026 Sophia Samantaroy The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading -> Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
Five Years after Landmark Diabetes Initiative: Cause to Celebrate but Even More to Accomplish 08/06/2026 Sophia Samantaroy The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading -> Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
Non-Profit Malaria and Neglected Diseases R&D Groups Pool Resources Amid Shrinking Global Budgets 08/06/2026 Kerry Cullinan Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading -> WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined 03/06/2026 Elaine Ruth Fletcher The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading -> ‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification 27/05/2026 Kerry Cullinan Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading -> BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions 08/05/2026 Felix Sassmannshausen This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts
World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Posts navigation Older posts